ADL — ADL Bionatur Solutions SA Share Price
- €21.88m
- €24.34m
- ESP3m
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 1.32 | ||
PEG Ratio (f) | |||
EPS Growth (f) | |||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | |||
Price to Tang. Book | |||
Price to Free Cashflow | |||
Price to Sales | |||
EV to EBITDA |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | |||
Return on Equity | |||
Operating Margin |
Financial Summary
Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ESPm | 1.31 | 2.39 | 23.32 | 2.13 | 2.52 | 86 | 96 | 19.17% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +16.22 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ADL BIONATUR SOLUTIONS SA (Bionatur), formerly known as Bioorganic Research and Services SA, is a Spain-based company engaged in the management and advice in the development of organic chemical processes carried out by third party entities. Among the chemical projects, the Company comprises the examination and interpretation of samples from waste treatment works, valuation of biological activities and retrosynthetic analysis. The Company's subsidiaries are BBD BioPhenix SL, a San Sebastian-based biotechnology company and Zera Intein Protein Solutions SL.
Directors
- Victor Vinolo CHM
- Jose Martin
- Felix Risco
- Juan Jose Infante
- Rosa Osuna
- Francisco Bascon Romero
- Ana de las Heras OTH
- Rocio Molina
- Rafael Jesus Contreras Chamorro
- Emilio Moraleda Martinez
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- March 1st, 2005
- Public Since
- June 14th, 2011
- No. of Employees
- 337
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Madrid Stock Exchange
- Shares in Issue
- 40,514,370
- Address
- Avenida del Desarrollo Tecnologico, JEREZ DE LA FRONTERA, 11591
- Web
- http://www.bionaturis.com/
- Phone
- +34 856818424
- Contact
- Jose Martin
- Auditors
- Ernst & Young S.L.
Upcoming events for ADL
FAQ
As of Today at 19:55 UTC, shares in ADL Bionatur Solutions SA are trading at €0.54. This share price information is delayed by 15 minutes.
Shares in ADL Bionatur Solutions SA last closed at €0.54 and the price had moved by -36.17% over the past 365 days. In terms of relative price strength the ADL Bionatur Solutions SA share price has underperformed the FTSE Global All Cap Index by -50.44% over the past year.
The overall consensus recommendation for ADL Bionatur Solutions SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
ADL Bionatur Solutions SA does not currently pay a dividend.
ADL Bionatur Solutions SA does not currently pay a dividend.
ADL Bionatur Solutions SA does not currently pay a dividend.
To buy shares in ADL Bionatur Solutions SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.54, shares in ADL Bionatur Solutions SA had a market capitalisation of €21.88m.
Here are the trading details for ADL Bionatur Solutions SA:
- Country of listing: Spain
- Exchange: MCE
- Ticker Symbol: ADL
Based on an overall assessment of its quality, value and momentum ADL Bionatur Solutions SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in ADL Bionatur Solutions SA is €3.10. That is 474.07% above the last closing price of €0.54.
Analysts covering ADL Bionatur Solutions SA currently have a consensus Earnings Per Share (EPS) forecast of ESP0 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ADL Bionatur Solutions SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -49.11%.
As of the last closing price of €0.54, shares in ADL Bionatur Solutions SA were trading -21.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ADL Bionatur Solutions SA PE ratio based on its reported earnings over the past 12 months is 2.44. The shares last closed at €0.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ADL Bionatur Solutions SA's management team is headed by:
- Victor Vinolo - CHM
- Jose Martin -
- Felix Risco -
- Juan Jose Infante -
- Rosa Osuna -
- Francisco Bascon Romero -
- Ana de las Heras - OTH
- Rocio Molina -
- Rafael Jesus Contreras Chamorro -
- Emilio Moraleda Martinez -
We do not have data on ADL Bionatur Solutions SA's shareholders